Relay Therapeutics, Inc. (RLAY) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
"main_header": {
"sid": 1243807,
"name": "Relay Therapeutics, Inc.",
"stock_name": "Relay Therapeutics, Inc.",
"full_name": "Relay Therapeutics, Inc.",
"name_url": "stocks-analysis/relay-therapeutics-inc",
"exchange": 210,
"exchangecode": "NAS",
"country_id": 2,
"currency": "USD",
"cmp": "8.00",
"chg": 0.51,
"chgp": "6.81%",
"dir": 1,
"prev_price": "7.49",
"mcapval": "699.99",
"mcap": "Micro Cap",
"scripcode": "",
"symbol": "",
"ind_name": "Pharmaceuticals & Biotechnology",
"ind_code": 2320,
"indexname": "S&P 500",
"isin": "US75943R1023",
"curr_date": "Dec 04",
"curr_time": "",
"bse_nse_vol": "2.41 M",
"exc_status": "Active",
"traded_date": "Dec 04, 2025",
"traded_date_str": "2025 12 04",
"score": "",
"scoreText": "",
"Live": 0,
"market_time": 0,
"is_blur": 1,
"is_blur_class": "blur-registerF-score-header",
"is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/relay-therapeutics-inc-1243807-210&utm_source=Spage_Header_Score",
"mojoone": {
"ismore": 0
}
},
"news": {
"results": [
{
"title": "Relay Therapeutics Reaches New 52-Week High of $7.64",
"link": "https://www.marketsmojo.com/news/stocks-in-action/relay-therapeutics-reaches-new-52-week-high-of-764-3659192",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/10/RelayTherapeuti_priceRelatedfactors_3659192.png",
"date": "2025-10-30 18:48:43",
"description": "Relay Therapeutics, Inc. achieved a new 52-week high of USD 7.64 on October 29, 2025, significantly up from its previous low of USD 1.78. Despite this milestone, the company has seen a 1-year performance decline, operates in the Pharmaceuticals & Biotechnology sector, and has a market cap of around USD 700 million."
},
{
"title": "Relay Therapeutics Hits New 52-Week High of $7.50, Marking Major Milestone",
"link": "https://www.marketsmojo.com/news/stocks-in-action/relay-therapeutics-hits-new-52-week-high-of-750-marking-major-milestone-3649290",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/10/RelayTherapeuti_priceRelatedfactors_3649290.png",
"date": "2025-10-27 17:00:05",
"description": "Relay Therapeutics, Inc. achieved a new 52-week high of USD 7.50 on October 24, 2025, despite a 1-year performance decline of 8.9%. The company, with a market capitalization of approximately USD 700 million, remains loss-making and does not offer dividends, reflecting its microcap status."
},
{
"title": "Relay Therapeutics Hits Day High with 9.62% Surge in Stock Price",
"link": "https://www.marketsmojo.com/news/stocks-in-action/relay-therapeutics-hits-day-high-with-962-surge-in-stock-price-3626745",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/10/RelayTherapeuti_priceRelatedfactors_3626745.png",
"date": "2025-10-16 19:05:17",
"description": "Relay Therapeutics, Inc. experienced a notable increase in stock performance on October 15, 2025, reaching an intraday high. The company has outperformed the S&P 500 over various periods, although it faces long-term challenges with significant declines in performance metrics and ongoing financial pressures."
},
{
"title": "Is Relay Therapeutics, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-relay-therapeutics-inc-technically-bullish-or-bearish-3599254",
"imagepath": "",
"date": "2025-10-07 12:22:26",
"description": "As of 3 October 2025, the technical trend for Relay Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, supported by bullish signals from both the Bollinger Bands and KST. However, the weekly RSI indicates a bearish stance, while the monthly RSI shows no signal. Daily moving averages are bullish, and Dow Theory reflects a mildly bullish outlook on both weekly and monthly time frames. Overall, the current technical stance is bullish, albeit with some mixed signals in the weekly indicators. Multi-period return data is not available for comparison with the S&P 500...."
},
{
"title": "Is Relay Therapeutics, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-relay-therapeutics-inc-technically-bullish-or-bearish-3593987",
"imagepath": "",
"date": "2025-10-06 12:12:33",
"description": "As of 3 October 2025, the technical trend for Relay Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands indicate bullish conditions. Daily moving averages are also bullish. However, the weekly RSI is bearish, and the monthly RSI shows no signal. The KST is bullish on a weekly basis and mildly bullish monthly, while Dow Theory and OBV are both mildly bullish across time frames. \n\nIn terms of performance, Relay Therapeutics has outperformed the S&P 500 over the past week and month, with returns of 6.00% and 33.33% respectively, compared to 1.09% and 4.15% for the index. However, the longer-term returns are significantly negative, with a 1-year return of -15.56% versus 17.82% for the S&P 500. Overall, the current stance is bullish, but mixed signals from the RSI suggest caution...."
},
{
"title": "Is Relay Therapeutics, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-relay-therapeutics-inc-technically-bullish-or-bearish-3592058",
"imagepath": "",
"date": "2025-10-05 11:57:43",
"description": "As of 3 October 2025, the technical trend for Relay Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The Bollinger Bands are bullish for both weekly and monthly time frames. Daily moving averages are also bullish. However, the weekly RSI is bearish, and the monthly RSI shows no signal. KST and OBV indicators are both bullish on a weekly basis and mildly bullish on a monthly basis. \n\nIn terms of performance, Relay Therapeutics has outperformed the S&P 500 over the past week and month, with returns of 6.00% and 33.33% compared to the S&P 500's 1.09% and 4.15%, respectively. However, the stock has underperformed over the longer term, with a 1-year return of -15.56% versus the S&P 500's 17.82%. Overall, the current technical stance is bullish, with moderate strength indicated by the mixed signals from the RSI and other indicator..."
},
{
"title": "Is Relay Therapeutics, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-relay-therapeutics-inc-technically-bullish-or-bearish-3547732",
"imagepath": "",
"date": "2025-09-20 20:01:53",
"description": "As of 12 September 2025, the technical trend for Relay Therapeutics, Inc. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages are also bullish, indicating positive momentum in the short term. However, the weekly RSI is bearish, suggesting some weakness, and the monthly RSI shows no signal. The Bollinger Bands indicate a bullish stance on the weekly but mildly bearish on the monthly. The KST is bullish weekly but bearish monthly, and the OBV shows a mildly bullish trend weekly but mildly bearish monthly. \n\nIn terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 10.44% and 31.12% respectively, compared to 1.05% and 2.33% for the index. However, over longer periods, the stock has significantly underperformed, with a 1-year return of -39.97% versus the S&P 500's 17..."
},
{
"title": "Is Relay Therapeutics, Inc. overvalued or undervalued?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-relay-therapeutics-inc-overvalued-or-undervalued-3544015",
"imagepath": "",
"date": "2025-09-20 18:35:10",
"description": "As of 2 November 2023, the valuation grade for Relay Therapeutics, Inc. has moved from does not qualify to risky, indicating a shift in perception regarding its financial health. The company appears to be overvalued given its negative performance metrics, including a Price to Book Value of 0.80 and an EV to EBITDA ratio of 0.34. Additionally, the Return on Equity (ROE) stands at a troubling -47.81%, reflecting significant losses relative to shareholder equity.\n\nIn comparison to its peers, Relay Therapeutics, Inc. has a less favorable EV to EBITDA ratio than Deciphera Pharmaceuticals, Inc. at -9.7157 and Tango Therapeutics, Inc. at -3.7404, further underscoring its relative weakness in valuation. Despite a recent uptick in stock price, the company's one-year return of -39.97% starkly contrasts with the S&P 500's 17.14% return, reinforcing the notion that Relay Therapeutics is struggling significantly compare..."
},
{
"title": "Relay Therapeutics, Inc. Experiences Revision in Stock Evaluation Amid Mixed Performance Indicators",
"link": "https://www.marketsmojo.com/news/stocks-in-action/relay-therapeutics-inc-technical-trend-shifts-from-mildly-bearish-to-mildly-bullish-amid-stock-price-increase-3522894",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/9/RelayTherapeuti_technicaldot_3522894.png",
"date": "2025-09-16 18:59:07",
"description": "Relay Therapeutics, Inc. has experienced notable shifts in its technical indicators, with current trading reflecting a mixed performance. Despite recent fluctuations, the company has struggled significantly over the past year, with stock returns declining sharply compared to the S&P 500, indicating ongoing challenges in the market."
}
],
"total": 14,
"sid": "1243807",
"stock_news_url": "https://www.marketsmojo.com/news/relay-therapeutics-inc-1243807"
},
"announcements": "",
"corporate_actions": {
"msg": "No corporate action Found"
}
}

News and Views

Relay Therapeutics Reaches New 52-Week High of $7.64

2025-10-30 18:48:43

Relay Therapeutics, Inc. achieved a new 52-week high of USD 7.64 on October 29, 2025, significantly up from its previous low of USD 1.78. Despite this milestone, the company has seen a 1-year performance decline, operates in the Pharmaceuticals & Biotechnology sector, and has a market cap of around USD 700 million.

Relay Therapeutics Hits New 52-Week High of $7.50, Marking Major Milestone

2025-10-27 17:00:05

Relay Therapeutics, Inc. achieved a new 52-week high of USD 7.50 on October 24, 2025, despite a 1-year performance decline of 8.9%. The company, with a market capitalization of approximately USD 700 million, remains loss-making and does not offer dividends, reflecting its microcap status.

Relay Therapeutics Hits Day High with 9.62% Surge in Stock Price

2025-10-16 19:05:17

Relay Therapeutics, Inc. experienced a notable increase in stock performance on October 15, 2025, reaching an intraday high. The company has outperformed the S&P 500 over various periods, although it faces long-term challenges with significant declines in performance metrics and ongoing financial pressures.

Is Relay Therapeutics, Inc. technically bullish or bearish?

2025-10-07 12:22:26

As of 3 October 2025, the technical trend for Relay Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, supported by bullish signals from both the Bollinger Bands and KST. However, the weekly RSI indicates a bearish stance, while the monthly RSI shows no signal. Daily moving averages are bullish, and Dow Theory reflects a mildly bullish outlook on both weekly and monthly time frames. Overall, the current technical stance is bullish, albeit with some mixed signals in the weekly indicators. Multi-period return data is not available for comparison with the S&P 500....

Is Relay Therapeutics, Inc. technically bullish or bearish?

2025-10-06 12:12:33

As of 3 October 2025, the technical trend for Relay Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands indicate bullish conditions. Daily moving averages are also bullish. However, the weekly RSI is bearish, and the monthly RSI shows no signal. The KST is bullish on a weekly basis and mildly bullish monthly, while Dow Theory and OBV are both mildly bullish across time frames. In terms of performance, Relay Therapeutics has outperformed the S&P 500 over the past week and month, with returns of 6.00% and 33.33% respectively, compared to 1.09% and 4.15% for the index. However, the longer-term returns are significantly negative, with a 1-year return of -15.56% versus 17.82% for the S&P 500. Overall, the current stance is bullish, but mixed signals from the RSI suggest caution....

Is Relay Therapeutics, Inc. technically bullish or bearish?

2025-10-05 11:57:43

As of 3 October 2025, the technical trend for Relay Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The Bollinger Bands are bullish for both weekly and monthly time frames. Daily moving averages are also bullish. However, the weekly RSI is bearish, and the monthly RSI shows no signal. KST and OBV indicators are both bullish on a weekly basis and mildly bullish on a monthly basis. In terms of performance, Relay Therapeutics has outperformed the S&P 500 over the past week and month, with returns of 6.00% and 33.33% compared to the S&P 500's 1.09% and 4.15%, respectively. However, the stock has underperformed over the longer term, with a 1-year return of -15.56% versus the S&P 500's 17.82%. Overall, the current technical stance is bullish, with moderate strength indicated by the mixed signals from the RSI and other indicator...

Is Relay Therapeutics, Inc. technically bullish or bearish?

2025-09-20 20:01:53

As of 12 September 2025, the technical trend for Relay Therapeutics, Inc. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages are also bullish, indicating positive momentum in the short term. However, the weekly RSI is bearish, suggesting some weakness, and the monthly RSI shows no signal. The Bollinger Bands indicate a bullish stance on the weekly but mildly bearish on the monthly. The KST is bullish weekly but bearish monthly, and the OBV shows a mildly bullish trend weekly but mildly bearish monthly. In terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 10.44% and 31.12% respectively, compared to 1.05% and 2.33% for the index. However, over longer periods, the stock has significantly underperformed, with a 1-year return of -39.97% versus the S&P 500's 17...

Is Relay Therapeutics, Inc. overvalued or undervalued?

2025-09-20 18:35:10

As of 2 November 2023, the valuation grade for Relay Therapeutics, Inc. has moved from does not qualify to risky, indicating a shift in perception regarding its financial health. The company appears to be overvalued given its negative performance metrics, including a Price to Book Value of 0.80 and an EV to EBITDA ratio of 0.34. Additionally, the Return on Equity (ROE) stands at a troubling -47.81%, reflecting significant losses relative to shareholder equity. In comparison to its peers, Relay Therapeutics, Inc. has a less favorable EV to EBITDA ratio than Deciphera Pharmaceuticals, Inc. at -9.7157 and Tango Therapeutics, Inc. at -3.7404, further underscoring its relative weakness in valuation. Despite a recent uptick in stock price, the company's one-year return of -39.97% starkly contrasts with the S&P 500's 17.14% return, reinforcing the notion that Relay Therapeutics is struggling significantly compare...

Relay Therapeutics, Inc. Experiences Revision in Stock Evaluation Amid Mixed Performance Indicators

2025-09-16 18:59:07

Relay Therapeutics, Inc. has experienced notable shifts in its technical indicators, with current trading reflecting a mixed performance. Despite recent fluctuations, the company has struggled significantly over the past year, with stock returns declining sharply compared to the S&P 500, indicating ongoing challenges in the market.

View All News